18F-ASIS

N/A

Report date: 2025/09/24 17:41:44

Base Information

Drug Name18F-ASIS

Drug Alias Name18F-radiolabeled active site inhibited factor VII18F-labeled Active-Site Inhibited Factor VII18F-ASIS18-F-ASIS

ClassificationDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radioactive diagnostic agent +[4]

Mechanisms of ActionPositron-emission tomography enhancers

TargetsNot applicable

Therapy Area/IndicationsUterine Cervical NeoplasmsLung NeoplasmsOvarian Neoplasms +[5]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryDenmark

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesRigshospitalet

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesRigshospitalet

Active IndicationsN/A

Inactive IndicationsUterine Cervical NeoplasmsLung NeoplasmsOvarian Neoplasms +[5]

Other Information

ATC CodeN/A